The Coronary Drug Eluting Stent (DES) is an advanced vascular implant designed to restore blood flow in narrowed or blocked coronary arteries while reducing the risk of restenosis through the controlled release of an antiproliferative drug. Engineered with a high-strength, thin-strut design and a biocompatible polymer coating, it offers excellent deliverability, flexibility, and radial strength for precise stent deployment and long-term vessel support. Its superior trackability and optimized drug-release technology contribute to improved clinical outcomes across a wide range of coronary interventions.